140 related articles for article (PubMed ID: 24449661)
1. Hypercalcemia and acromegaly--clarifying the connections. A case report and review of the literature.
Manroa P; Kannan S; Hatipoglu B; Licata A
Endocr Pract; 2014 May; 20(5):e86-90. PubMed ID: 24449661
[TBL] [Abstract][Full Text] [Related]
2. Acromegaly as a cause of 1,25-dihydroxyvitamin D-dependent hypercalcemia: case reports and review of the literature.
Shah R; Licata A; Oyesiku NM; Ioachimescu AG
Pituitary; 2012 Dec; 15 Suppl 1():S17-22. PubMed ID: 21188640
[TBL] [Abstract][Full Text] [Related]
3. Acromegaly and non-parathyroid hormone-dependent hypercalcemia: a case report and literature review.
Shi S; Zhang L; Yu Y; Wang C; Li J
BMC Endocr Disord; 2021 May; 21(1):90. PubMed ID: 33933067
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcemia in a patient with primary hyperparathyroidism and acromegaly: distinct roles of growth hormone and parathyroid hormone in the development of hypercalcemia.
Ueda M; Inaba M; Tahara H; Imanishi Y; Goto H; Nishizawa Y
Intern Med; 2005 Apr; 44(4):307-10. PubMed ID: 15897641
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid carcinoma during pregnancy: a novel pathogenic CDC73 mutation - a case report.
Dematapitiya C; Perera C; Pathmanathan S; Subasinghe V; Anandagoda G; Dissanayaka V; Wijenayake U; Dissanayake P; Gamage K; Wijewickrama P; Sumanatilleke M
BMC Endocr Disord; 2022 Oct; 22(1):259. PubMed ID: 36284286
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. Type 1 diabetes associated with asymptomatic acromegaly successfully treated with surgery after pregnancy: a case report.
Iwai H; Ito H; Ri S; Harada T; Hirota N; Yamauchi T; Miyatake T; Ohno Y; Aoki N
Endocr J; 2005 Aug; 52(4):413-20. PubMed ID: 16127208
[TBL] [Abstract][Full Text] [Related]
8. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
9. A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content.
Takahashi F; Finch JL; Denda M; Dusso AS; Brown AJ; Slatopolsky E
Am J Kidney Dis; 1997 Jul; 30(1):105-12. PubMed ID: 9214408
[TBL] [Abstract][Full Text] [Related]
10. Sarcoidosis within a pituitary adenoma.
Rubin MR; Bruce JN; Khandji AG; Freda PU
Pituitary; 2001 Aug; 4(3):195-202. PubMed ID: 12138993
[TBL] [Abstract][Full Text] [Related]
11. Impact of preoperative pasireotide therapy on invasive octreotide-resistant acromegaly.
Yamamoto R; Robert Shima K; Igawa H; Kaikoi Y; Sasagawa Y; Hayashi Y; Inoshita N; Fukuoka H; Takahashi Y; Takamura T
Endocr J; 2018 Oct; 65(10):1061-1067. PubMed ID: 30078825
[TBL] [Abstract][Full Text] [Related]
12. Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.
Kaltsas GA; Isidori AM; Florakis D; Trainer PJ; Camacho-Hubner C; Afshar F; Sabin I; Jenkins JP; Chew SL; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2001 Apr; 86(4):1645-52. PubMed ID: 11297598
[TBL] [Abstract][Full Text] [Related]
13. 1α,24(S)(OH)2D2 normalizes bone morphology and serum parathyroid hormone without hypercalcemia in 25-hydroxyvitamin D-1-hydroxylase (CYP27B1)-deficient mice, an animal model of vitamin D deficiency with secondary hyperparathyroidism.
St-Arnaud R; Arabian A; Yu VW; Akhouayri O; Knutson JC; Strugnell SA
J Endocrinol Invest; 2008 Aug; 31(8):711-7. PubMed ID: 18852532
[TBL] [Abstract][Full Text] [Related]
14. Case of Acromegaly Caused by Rathke Cleft Cyst Mimicking Plurihormonal Pituitary Adenoma.
Morinaga Y; Nii K; Sakamoto K; Inoue R; Mitsutake T; Hanada H
World Neurosurg; 2019 Jun; 126():570-575. PubMed ID: 30862574
[TBL] [Abstract][Full Text] [Related]
15. Bromocriptine, a dopamine agonist, increases growth hormone secretion in a patient with acromegaly.
Arihara Z; Sakurai K; Yamashita R; Niitsuma S; Ueno T; Yamamura N; Yamada S; Inoshita N; Takahashi K
Tohoku J Exp Med; 2014 Oct; 234(2):129-35. PubMed ID: 25253414
[TBL] [Abstract][Full Text] [Related]
16. [Lowered ghrelin levels in acromegaly—normalization after treatment].
Kozakowski J; Rabijewski M; Zgliczyński W
Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of 1,25(OH)2D production by hypercalcemia in osteitis fibrosa cystica: influence on parathyroid hormone secretion and hungry bone disease.
Brossard JH; Garon J; Lepage R; Gascon-Barré M; D'Amour P
Bone Miner; 1993 Oct; 23(1):15-26. PubMed ID: 8274876
[TBL] [Abstract][Full Text] [Related]
18. Cabergoline in the treatment of acromegaly: a study in 64 patients.
Abs R; Verhelst J; Maiter D; Van Acker K; Nobels F; Coolens JL; Mahler C; Beckers A
J Clin Endocrinol Metab; 1998 Feb; 83(2):374-8. PubMed ID: 9467544
[TBL] [Abstract][Full Text] [Related]
19. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
[TBL] [Abstract][Full Text] [Related]
20. A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia.
Slatopolsky E; Finch J; Ritter C; Denda M; Morrissey J; Brown A; DeLuca H
Am J Kidney Dis; 1995 Nov; 26(5):852-60. PubMed ID: 7485144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]